Clinical trial
Evaluation of the Efficacy and Safety of PTC299 in Hospitalized Subjects With COVID-19 (FITE19)
NCT04439071 is registered in ClinicalTrials.gov with PTC Therapeutics as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of the Efficacy and Safety of PTC299 in Hospitalized Subjects With COVID-19 (FITE19)
- Lead sponsor
- PTC Therapeutics
- Phase
- Phase 2/3
- Overall status
- Terminated
- Start date
- July 9, 2020
- Completion date
- July 20, 2022
- Enrollment
- 189 (actual)
- Sites
- 41
Conditions
As the registry lists them; a condition with its own page is linked.